Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 31, 2007
Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancerDaria Handkiewicz-Junak, Jan Wloch, Jozef Roskosz, et al.
Archives of Medical Science : AMS|September 26, 2022
Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomesAleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska, et al.
Thyroid Research|November 3, 2010
Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCiAleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska-Suwińska, et al.
Thyroid Research|August 4, 2009
13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 studyDaria Handkiewicz-Junak, Jozef Roskosz, Kornelia Hasse-Lazar, et al.
Nuclear Medicine and Molecular Imaging|November 15, 2019
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid CarcinomaJolanta Krajewska, Michal Jarzab, Aleksandra Kukulska, et al.
Endocrine Connections|November 29, 2019
The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinomaAleksandra Kukulska, Jolanta Krajewska, Zofia Kolosza, et al.
Pageof 1